Skip to main content
Top
Published in: BMC Neurology 1/2015

Open Access 01-12-2015 | Research article

Interaction of physical function, quality of life and depression in Amyotrophic lateral sclerosis: characterization of a large patient cohort

Authors: Sonja Körner, Katja Kollewe, Susanne Abdulla, Antonia Zapf, Reinhard Dengler, Susanne Petri

Published in: BMC Neurology | Issue 1/2015

Login to get access

Abstract

Background

Due to lack of any curative therapy for ALS, symptomatic treatment and maintenance of quality of life (QoL) is very important. We aimed to characterize the affected domains of QoL in ALS patients and to identify factors which are associated with reduced QoL and increased depression.

Methods

159 ALS patients answered standardized questionnaires (Beck Depression Inventory-II, SF-36 Health Survey questionnaire, revised ALS functional rating scale). Multiple regression analysis was used to identify correlations between clinical features of ALS patients and depression/QoL scores. In addition, QoL data from ALS patients were compared to age-matched reference values representing the German normal population.

Results

QoL of ALS patients was reduced in nearly all SF-36-categories. Progression of physical impairment was positively correlated with depression but reduced QoL scores only in items directly related to physical function. However, QoL was considerably influenced by depression, independently from physical impairment. Regarding distinct patient characteristics one of the most interesting findings was that increasing age was correlated with significantly worse QoL results regarding social functioning.

Conclusions

Depressive symptoms had a strong influence on QoL, hence their detection and treatment is of particular importance. Different domains of QoL are differently affected in subgroups of ALS patients. Being aware of these differences can be valuable for both ALS professional and family caregivers and physicians.
Appendix
Available only for authorised users
Literature
2.
go back to reference Kubler A, Winter S, Ludolph AC, Hautzinger M, Birbaumer N. Severity of depressive symptoms and quality of life in patients with amyotrophic lateral sclerosis. Neurorehabil Neural Repair. 2005;19:182–93.CrossRefPubMed Kubler A, Winter S, Ludolph AC, Hautzinger M, Birbaumer N. Severity of depressive symptoms and quality of life in patients with amyotrophic lateral sclerosis. Neurorehabil Neural Repair. 2005;19:182–93.CrossRefPubMed
3.
go back to reference Kiebert GM, Green C, Murphy C, Mitchell JD, O’Brien M, Burrell A, et al. Patients’ health-related quality of life and utilities associated with different stages of amyotrophic lateral sclerosis. J Neurol Sci. 2001;191:87–93.CrossRefPubMed Kiebert GM, Green C, Murphy C, Mitchell JD, O’Brien M, Burrell A, et al. Patients’ health-related quality of life and utilities associated with different stages of amyotrophic lateral sclerosis. J Neurol Sci. 2001;191:87–93.CrossRefPubMed
4.
go back to reference Lule D, Hacker S, Ludolph A, Birbaumer N, Kubler A. Depression and quality of life in patients with amyotrophic lateral sclerosis. Dtsch Arztebl Int. 2008;105:397–403.PubMedPubMedCentral Lule D, Hacker S, Ludolph A, Birbaumer N, Kubler A. Depression and quality of life in patients with amyotrophic lateral sclerosis. Dtsch Arztebl Int. 2008;105:397–403.PubMedPubMedCentral
5.
go back to reference McDonald ER, Wiedenfeld SA, Hillel A, Carpenter CL, Walter RA. Survival in amyotrophic lateral sclerosis. The role of psychological factors. Arch Neurol. 1994;51:17–23.CrossRefPubMed McDonald ER, Wiedenfeld SA, Hillel A, Carpenter CL, Walter RA. Survival in amyotrophic lateral sclerosis. The role of psychological factors. Arch Neurol. 1994;51:17–23.CrossRefPubMed
6.
go back to reference Rabkin JG, Albert SM, Del Bene ML, O’Sullivan I, Tider T, Rowland LP, et al. Prevalence of depressive disorders and change over time in late-stage ALS. Neurology. 2005;65:62–7.CrossRefPubMedPubMedCentral Rabkin JG, Albert SM, Del Bene ML, O’Sullivan I, Tider T, Rowland LP, et al. Prevalence of depressive disorders and change over time in late-stage ALS. Neurology. 2005;65:62–7.CrossRefPubMedPubMedCentral
7.
go back to reference Robbins RA, Simmons Z, Bremer BA, Walsh SM, Fischer S. Quality of life in ALS is maintained as physical function declines. Neurology. 2001;56:442–4.CrossRefPubMed Robbins RA, Simmons Z, Bremer BA, Walsh SM, Fischer S. Quality of life in ALS is maintained as physical function declines. Neurology. 2001;56:442–4.CrossRefPubMed
8.
go back to reference Pagnini F, Manzoni GM, Tagliaferri A, Gibbons CJ. Depression and disease progression in amyotrophic lateral sclerosis: A comprehensive meta-regression analysis. J Health Psychol. 2014. Pagnini F, Manzoni GM, Tagliaferri A, Gibbons CJ. Depression and disease progression in amyotrophic lateral sclerosis: A comprehensive meta-regression analysis. J Health Psychol. 2014.
9.
go back to reference Hunter MD, Robinson IC, Neilson S. The functional and psychological status of patients with amyotrophic lateral sclerosis: some implications for rehabilitation. Disabil Rehabil. 1993;15:119–26.CrossRefPubMed Hunter MD, Robinson IC, Neilson S. The functional and psychological status of patients with amyotrophic lateral sclerosis: some implications for rehabilitation. Disabil Rehabil. 1993;15:119–26.CrossRefPubMed
10.
go back to reference Oh H, Sin MK, Schepp KG, Choi-Kwon S. Depressive symptoms and functional impairment among amyotrophic lateral sclerosis patients in South Korea. Rehabil Nurs. 2012;37:136–44.CrossRefPubMed Oh H, Sin MK, Schepp KG, Choi-Kwon S. Depressive symptoms and functional impairment among amyotrophic lateral sclerosis patients in South Korea. Rehabil Nurs. 2012;37:136–44.CrossRefPubMed
11.
go back to reference Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.CrossRefPubMed Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.CrossRefPubMed
12.
go back to reference Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169:13–21.CrossRefPubMed Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169:13–21.CrossRefPubMed
13.
go back to reference Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess. 1996;67:588–97.CrossRefPubMed Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess. 1996;67:588–97.CrossRefPubMed
14.
go back to reference Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–83.CrossRefPubMed Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–83.CrossRefPubMed
15.
go back to reference Jenkinson C, Fitzpatrick R, Swash M, Peto V. The ALS Health Profile Study: quality of life of amyotrophic lateral sclerosis patients and carers in Europe. J Neurol. 2000;247:835–40.CrossRefPubMed Jenkinson C, Fitzpatrick R, Swash M, Peto V. The ALS Health Profile Study: quality of life of amyotrophic lateral sclerosis patients and carers in Europe. J Neurol. 2000;247:835–40.CrossRefPubMed
16.
go back to reference Jenkinson C, Hobart J, Chandola T, Fitzpatrick R, Peto V, Swash M. Use of the short form health survey (SF-36) in patients with amyotrophic lateral sclerosis: tests of data quality, score reliability, response rate and scaling assumptions. J Neurol. 2002;249:178–83.CrossRefPubMed Jenkinson C, Hobart J, Chandola T, Fitzpatrick R, Peto V, Swash M. Use of the short form health survey (SF-36) in patients with amyotrophic lateral sclerosis: tests of data quality, score reliability, response rate and scaling assumptions. J Neurol. 2002;249:178–83.CrossRefPubMed
17.
go back to reference Bullinger M, Kirchberger I. SF-36 Fragebogen zum Gesundheitszustand. Hogrefe: Verlag für Psychologie; 1998. Bullinger M, Kirchberger I. SF-36 Fragebogen zum Gesundheitszustand. Hogrefe: Verlag für Psychologie; 1998.
18.
go back to reference Jäger S, Jagla M, Morefeld M, Türk T, Witzke O, Reimer J, et al. Gesundheitsbezogene Lebensqualität bei Patienten nach Nierentransplantation - Lässt sich die Skalenstruktur des SF-36 replizieren? Diagnostica. 2009;55:245–54.CrossRef Jäger S, Jagla M, Morefeld M, Türk T, Witzke O, Reimer J, et al. Gesundheitsbezogene Lebensqualität bei Patienten nach Nierentransplantation - Lässt sich die Skalenstruktur des SF-36 replizieren? Diagnostica. 2009;55:245–54.CrossRef
19.
go back to reference Reimer J, Rensing A, Haasen C, Philipp T, Pietruck F, Franke GH. The impact of living-related kidney transplantation on the donor’s life. Transplantation. 2006;81:1268–73.CrossRefPubMed Reimer J, Rensing A, Haasen C, Philipp T, Pietruck F, Franke GH. The impact of living-related kidney transplantation on the donor’s life. Transplantation. 2006;81:1268–73.CrossRefPubMed
20.
go back to reference Blackhall LJ. Amyotrophic lateral sclerosis and palliative care: where we are, and the road ahead. Muscle Nerve. 2012;45:311–8.CrossRefPubMed Blackhall LJ. Amyotrophic lateral sclerosis and palliative care: where we are, and the road ahead. Muscle Nerve. 2012;45:311–8.CrossRefPubMed
21.
go back to reference Neudert C, Wasner M, Borasio GD. Patients’ assessment of quality of life instruments: a randomised study of SIP, SF-36 and SEIQoL-DW in patients with amyotrophic lateral sclerosis. J Neurol Sci. 2001;191:103–9.CrossRefPubMed Neudert C, Wasner M, Borasio GD. Patients’ assessment of quality of life instruments: a randomised study of SIP, SF-36 and SEIQoL-DW in patients with amyotrophic lateral sclerosis. J Neurol Sci. 2001;191:103–9.CrossRefPubMed
22.
go back to reference Neudert C, Wasner M, Borasio GD. Individual quality of life is not correlated with health-related quality of life or physical function in patients with amyotrophic lateral sclerosis. J Palliat Med. 2004;7:551–7.CrossRefPubMed Neudert C, Wasner M, Borasio GD. Individual quality of life is not correlated with health-related quality of life or physical function in patients with amyotrophic lateral sclerosis. J Palliat Med. 2004;7:551–7.CrossRefPubMed
23.
go back to reference Chio A, Gauthier A, Montuschi A, Calvo A, Di VN, Ghiglione P, et al. A cross sectional study on determinants of quality of life in ALS. J Neurol Neurosurg Psychiatry. 2004;75:1597–601.CrossRefPubMedPubMedCentral Chio A, Gauthier A, Montuschi A, Calvo A, Di VN, Ghiglione P, et al. A cross sectional study on determinants of quality of life in ALS. J Neurol Neurosurg Psychiatry. 2004;75:1597–601.CrossRefPubMedPubMedCentral
24.
go back to reference Pagnini F, Lunetta C, Banfi P, Rossi G, Fossati F, Marconi A, et al. Pain in Amyotrophic Lateral Sclerosis: a psychological perspective. Neurol Sci. 2012;33:1193–6.CrossRefPubMed Pagnini F, Lunetta C, Banfi P, Rossi G, Fossati F, Marconi A, et al. Pain in Amyotrophic Lateral Sclerosis: a psychological perspective. Neurol Sci. 2012;33:1193–6.CrossRefPubMed
25.
go back to reference Ganzini L, Johnston WS, Hoffman WF. Correlates of suffering in amyotrophic lateral sclerosis. Neurology. 1999;52:1434–40.CrossRefPubMed Ganzini L, Johnston WS, Hoffman WF. Correlates of suffering in amyotrophic lateral sclerosis. Neurology. 1999;52:1434–40.CrossRefPubMed
26.
go back to reference Hogg KE, Goldstein LH, Leigh PN. The psychological impact of motor neurone disease. Psychol Med. 1994;24:625–32.CrossRefPubMed Hogg KE, Goldstein LH, Leigh PN. The psychological impact of motor neurone disease. Psychol Med. 1994;24:625–32.CrossRefPubMed
27.
go back to reference Rabkin JG, Wagner GJ, Del BM. Resilience and distress among amyotrophic lateral sclerosis patients and caregivers. Psychosom Med. 2000;62:271–9.CrossRefPubMed Rabkin JG, Wagner GJ, Del BM. Resilience and distress among amyotrophic lateral sclerosis patients and caregivers. Psychosom Med. 2000;62:271–9.CrossRefPubMed
28.
go back to reference Simmons Z, Bremer BA, Robbins RA, Walsh SM, Fischer S. Quality of life in ALS depends on factors other than strength and physical function. Neurology. 2000;55:388–92.CrossRefPubMed Simmons Z, Bremer BA, Robbins RA, Walsh SM, Fischer S. Quality of life in ALS depends on factors other than strength and physical function. Neurology. 2000;55:388–92.CrossRefPubMed
29.
go back to reference Badger TA. Depression, Psychological Resources, and Health-Related Quality of Life in Older Adults 75 and Above. J Clin Geropsychol. 2001;7:189–200.CrossRef Badger TA. Depression, Psychological Resources, and Health-Related Quality of Life in Older Adults 75 and Above. J Clin Geropsychol. 2001;7:189–200.CrossRef
30.
go back to reference Lou JS, Reeves A, Benice T, Sexton G. Fatigue and depression are associated with poor quality of life in ALS. Neurology. 2003;60:122–3.CrossRefPubMed Lou JS, Reeves A, Benice T, Sexton G. Fatigue and depression are associated with poor quality of life in ALS. Neurology. 2003;60:122–3.CrossRefPubMed
31.
go back to reference Gibbons C, Thornton E, Ealing J, Shaw P, Talbot K, Tennant A, et al. The impact of fatigue and psychosocial variables on quality of life for patients with motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:537–45.CrossRefPubMed Gibbons C, Thornton E, Ealing J, Shaw P, Talbot K, Tennant A, et al. The impact of fatigue and psychosocial variables on quality of life for patients with motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:537–45.CrossRefPubMed
32.
go back to reference Moore MJ, Moore PB, Shaw PJ. Mood disturbances in motor neurone disease. J Neurol Sci. 1998;160 Suppl 1:S53–6.CrossRefPubMed Moore MJ, Moore PB, Shaw PJ. Mood disturbances in motor neurone disease. J Neurol Sci. 1998;160 Suppl 1:S53–6.CrossRefPubMed
33.
go back to reference Korner S, Kollewe K, Ilsemann J, Muller-Heine A, Dengler R, Krampfl K, et al. Prevalence and prognostic impact of comorbidities in Amyotrophic Lateral Sclerosis. Eur J Neurol. 2012;20(4):647.CrossRefPubMed Korner S, Kollewe K, Ilsemann J, Muller-Heine A, Dengler R, Krampfl K, et al. Prevalence and prognostic impact of comorbidities in Amyotrophic Lateral Sclerosis. Eur J Neurol. 2012;20(4):647.CrossRefPubMed
34.
go back to reference Wicks P, Abrahams S, Masi D, Hejda-Forde S, Leigh PN, Goldstein LH. Prevalence of depression in a 12-month consecutive sample of patients with ALS. Eur J Neurol. 2007;14:993–1001.CrossRefPubMed Wicks P, Abrahams S, Masi D, Hejda-Forde S, Leigh PN, Goldstein LH. Prevalence of depression in a 12-month consecutive sample of patients with ALS. Eur J Neurol. 2007;14:993–1001.CrossRefPubMed
35.
go back to reference Taylor L, Wicks P, Leigh PN, Goldstein LH. Prevalence of depression in amyotrophic lateral sclerosis and other motor disorders. Eur J Neurol. 2010;17:1047–53.CrossRefPubMed Taylor L, Wicks P, Leigh PN, Goldstein LH. Prevalence of depression in amyotrophic lateral sclerosis and other motor disorders. Eur J Neurol. 2010;17:1047–53.CrossRefPubMed
36.
go back to reference Ferentinos P, Paparrigopoulos T, Rentzos M, Zouvelou V, Alexakis T, Evdokimidis I. Prevalence of major depression in ALS: comparison of a semi-structured interview and four self-report measures. Amyotroph Lateral Scler. 2011;12:297–302.CrossRefPubMed Ferentinos P, Paparrigopoulos T, Rentzos M, Zouvelou V, Alexakis T, Evdokimidis I. Prevalence of major depression in ALS: comparison of a semi-structured interview and four self-report measures. Amyotroph Lateral Scler. 2011;12:297–302.CrossRefPubMed
37.
go back to reference Gibbons CJ, Mills RJ, Thornton EW, Ealing J, Mitchell JD, Shaw PJ, et al. Rasch analysis of the hospital anxiety and depression scale (HADS) for use in motor neurone disease. Health Qual Life Outcomes. 2011;9:82.CrossRefPubMedPubMedCentral Gibbons CJ, Mills RJ, Thornton EW, Ealing J, Mitchell JD, Shaw PJ, et al. Rasch analysis of the hospital anxiety and depression scale (HADS) for use in motor neurone disease. Health Qual Life Outcomes. 2011;9:82.CrossRefPubMedPubMedCentral
38.
Metadata
Title
Interaction of physical function, quality of life and depression in Amyotrophic lateral sclerosis: characterization of a large patient cohort
Authors
Sonja Körner
Katja Kollewe
Susanne Abdulla
Antonia Zapf
Reinhard Dengler
Susanne Petri
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2015
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-015-0340-2

Other articles of this Issue 1/2015

BMC Neurology 1/2015 Go to the issue